Pfizer’s And Novo’s Competing Bids For Metsera Devolve Into Lawsuits, Name Calling

New Action Claims Antitrust Violations

 
• By Mandy Jackson
  
Pfizer accused Novo of anticompetitive actions, while Novo called Pfizer's lawsuits "desperate" (Shutterstock)

More from Scrip

More from Deals